Table: Medipal Holdings - 9-MTH group results
Feb 9 (Reuters)-
Medipal Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.91 trln 2.81 trln 3.79 trln
(+3.7 pct) (+3.4 pct) (+3.1 pct)
Operating 43.18 45.37 52.00
(-4.8 pct) (+21.9 pct) (-6.5 pct)
Recurring 61.31 56.71 69.00
(+8.1 pct) (+12.9 pct) (+5.7 pct)
Net 37.41 36.24 34.50
(+3.2 pct) (+28.1 pct) (-14.3 pct)
EPS 181.48 yen 173.66 yen 167.63 yen
Ann Div 62.00 yen 64.00 yen
-Q2 div 32.00 yen 30.00 yen
-Q4 div 32.00 yen 32.00 yen
NOTE - Medipal Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7459.T
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows